Aloop Therapeutics ApS
Private limited companyCVR 43257498København ØActive
Aloop Therapeutics ApS is a private limited company, based in København Ø, active in manufacture of pharmaceutical preparations, founded in 2022. The company made a loss in both 2024 and 2025, most recently DKK 69,892. 8 other companies in the database are registered at the same address.
Key figures · financial year 2025
What has changed
calculated from recorded figures and datesFinancials: 2025 against 2024
- The loss got smaller: from DKK 1.3m to DKK 69,892 (2024 → 2025).
Employees
- 3 more employees than a year earlier: 6 (03/2024) against 3 (03/2023).
Management and owners, last 24 months
- New in management: Rodolphe Clerval (ceo, 22/01/2025).
- Stepped down: Søren Sylvester Skjærbæk (ceo, 22/01/2025), Emmanuelle Coutanceau (board member, 22/01/2025) and Camilla Petrycer Hansen (chair of the board, 22/01/2025).
- New owners registered: Coave Therapeutics (08/01/2025).
- No longer registered as owner: Novo Holdings A/S (08/01/2025).
Registrations, last 24 months
- 20/02/2025: Moved to Sundkrogsgade 21, 2100 København Ø
- 30/10/2024: Moved to Nordre Fasanvej 215, 2000 Frederiksberg
Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.
Financial statements
Financial years 2023–2025 · amounts in DKK thousandEquity and net profit
| 2023 | 2024 | 2025 | Change | |
|---|---|---|---|---|
| Revenue | not stated | not stated | not stated | – |
| Gross profit | −9,058 | −1,323 | −274 | +79.3% |
| Operating profit (EBIT) | −11,904 | −2,760 | −274 | +90.1% |
| Profit before tax | −11,524 | −1,903 | 130 | +106.8% |
| Net profit | −8,809 | −1,295 | −70 | +94.6% |
| Total assets | 34,250 | 30,814 | 30,839 | +0.1% |
| Equity | 32,022 | 30,727 | 30,657 | −0.2% |
| Liabilities | 2,228 | 87 | 182 | +109.6% |
| Cash and cash equivalents | 30,811 | 30,191 | 30,727 | +1.8% |
| Average number of employees | 8 | – | 0 | – |
Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.
Download the figures as CSV · free with an account, amounts in whole DKK
Signals from the financial statements
calculated from the 2025 figuresLoss for 3 years in a row
Net result has been negative in 2023–2025.
How is this calculated?
Net result is negative in the two or more latest annual reports in a row.
The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.
Annual reports
3 financial years| Financial year | Period | Published | Figures for | Documents |
|---|---|---|---|---|
| 2025 | 01/01/2025 – 31/12/2025 | 24/06/2026 | The company | PDF not statedXBRL |
| 2024 | 01/01/2024 – 31/12/2024 | 24/05/2025 | The company | PDF not statedXBRL |
| 2023 | 01/01/2023 – 31/12/2023 | 01/03/2024 | The company | PDFXBRL |
The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.
Employees
monthly figures from CVRPosition in the industry
59 companies in the databaseComparison with the other companies in manufacture of pharmaceutical preparations based on the latest financial year.
Industry median: gross profit DKK 2.8m, net profit −DKK 2.2m, equity DKK 5.2m, 10 employees.
Compared with similar companies
size, age and company form| Group | Gross profit | Equity |
|---|---|---|
| Companies with fewer than 20 employees69,967 companies in the comparison | No. 67,325of 69,742 Better than 3% | No. 4,402of 69,964 Better than 94% |
| Same industry and fewer than 20 employees37 companies in the comparison | No. 20of 36 Better than 46% | No. 6of 37 Better than 86% |
| Companies that are founded within the last five years16,662 companies in the comparison | No. 15,944of 16,614 Better than 4% | No. 442of 16,661 Better than 97% |
| All companies of type ApS66,508 companies in the comparison | No. 64,488of 66,379 Better than 3% | No. 3,115of 66,505 Better than 95% |
The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.
Compare with the industry
Manufacture of pharmaceutical preparations- Aloop Therapeutics ApS−DKK 274k
- Novo Nordisk A/SDKK 250.3bn
- H. Lundbeck A/SDKK 20.4bn
- Aloop Therapeutics ApS−DKK 69,892
- Novo Nordisk A/SDKK 102.4bn
- H. Lundbeck A/SDKK 3.2bn
- Aloop Therapeutics ApSDKK 30.7m
- Novo Nordisk A/SDKK 194bn
- H. Lundbeck A/SDKK 24.9bn
- Aloop Therapeutics ApS6
- Novo Nordisk A/S27,279
- H. Lundbeck A/S2,261
Latest financial year per company. Choose up to three companies from the largest in the industry.
Owners and group
from the Public Ownership Register- Coave Therapeutics100%
Management
1 active registrationsExecutive management
| Name | Role | Appointed |
|---|---|---|
| Rodolphe Clerval | CEO | 22/01/2025 |
- Founders
- Novo Holdings A/S
Former management (6)
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| Søren Sylvester Skjærbæk | CEO | 06/05/2022 | 22/01/2025 |
| Thomas Kirkegaard Jensen | Director | 06/05/2022 | 31/03/2024 |
| Camilla Petrycer Hansen | Board member | 06/05/2022 | 03/07/2023 |
| Jens Bo Rode Hansen | Chair of the board | 06/05/2022 | 04/07/2023 |
| Emmanuelle Coutanceau | Board member | 06/05/2022 | 22/01/2025 |
| Camilla Petrycer Hansen | Chair of the board | 04/07/2023 | 22/01/2025 |
Signing rule: Selskabet tegnes af en direktør.
Address and production units
1 active production unitsSundkrogsgade 21
2100 København Ø
København Municipality · Postcode 2100
Other companies at the address (8)
- Remote Technology ApSBusiness and other management consultancy activities
- JD Sports Fashion Denmark ApSWholesale of clothing
- Csc (denmark) ApSBusiness and other management consultancy activities
- Edyn Aparthotel Denmark ApSHotels and similar accommodation
- Hotel Co 51 Denmark ApSHotels and similar accommodation
| Production unit | Address | Employees | P number |
|---|---|---|---|
| Aloop Therapeutics ApS | Sundkrogsgade 21, 2100 København Ø | 2 | 1028247369 |
Purpose
Selskabets formål er forskning, udvikling og kommercialisering af lægemidler.
The purpose is quoted from the register in Danish.
Changes year by year
25 registered events20261 changeaccounts 1
- AccountsAnnual report for 2025 published
20258 changesaccounts 1 · address 1 · management 4 · ownership 2
- AccountsAnnual report for 2024 published
- AddressMoved to Sundkrogsgade 21, 2100 København Ø
- ManagementRodolphe Clerval appointed ceo
- ManagementCamilla Petrycer Hansen stepped down as chair of the board
- ManagementSøren Sylvester Skjærbæk stepped down as ceo
- ManagementEmmanuelle Coutanceau stepped down as board member
- OwnershipCoave Therapeutics registered as owner (100%)
- OwnershipNovo Holdings A/S is no longer registered as owner
20243 changesaddress 1 · management 1 · accounts 1
- AddressMoved to Nordre Fasanvej 215, 2000 Frederiksberg
- ManagementThomas Kirkegaard Jensen stepped down as director
- AccountsAnnual report for 2023 published
20234 changesmanagement 3 · capital 1
- ManagementCamilla Petrycer Hansen appointed chair of the board
- ManagementJens Bo Rode Hansen stepped down as chair of the board
- ManagementCamilla Petrycer Hansen stepped down as board member
- CapitalShare capital changed from 100,000 DKK to 300,000 DKK
20229 changesaddress 2 · founded 1 · management 5 · ownership 1
- AddressMoved to Ole Maaløes Vej 3, 2, 2200 København N
- AddressMoved to Stærmosevej 12, 7120 Vejle Øst
- FoundedRegistered as Aloop Therapeutics ApS
- ManagementCamilla Petrycer Hansen appointed board member
- ManagementSøren Sylvester Skjærbæk appointed ceo
- ManagementEmmanuelle Coutanceau appointed board member
- ManagementJens Bo Rode Hansen appointed chair of the board
- ManagementThomas Kirkegaard Jensen appointed director
- OwnershipNovo Holdings A/S registered as owner (100%)
Related companies
Same industry in København
- H. Lundbeck A/S2,261 employees
- AJ Vaccines A/S499 employees
- Tetra Pharm Technologies ApS39 employees
- Motilitycount ApS29 employees
- Freya Biosciences ApS18 employees
- Zerion Pharma A/S15 employees
Same people in management
- Actas A/Svia Søren Sylvester Skjærbæk
- NRGI A.m.b.a.via Søren Sylvester Skjærbæk
- Hemab ApSvia Camilla Petrycer Hansen
- Orbis Medicines ApSvia Søren Sylvester Skjærbæk
- Minervax ApSvia Emmanuelle Coutanceau
- Muna Therapeutics ApSvia Camilla Petrycer Hansen
Largest in the industry
- Novo Nordisk A/SDKK 250.3bn
- H. Lundbeck A/SDKK 20.4bn
- Leo Pharma A/SDKK 8.2bn
- Alk-abelló A/SDKK 4.2bn
- Bavarian Nordic A/SDKK 3bn
- Pharmacosmos A/SDKK 1.6bn
Source and updates
The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.